Can We Identify the Active Ingredients of Behaviour Change Interventions for Coronary Heart Disease Patients? A

Laura Goodwin1, Giovanni Ostuzzi2, Nadia Khan3

  • 1Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.

Plos One
|April 23, 2016
PubMed

Insights

Behavioral interventions for coronary heart disease (CHD) patients, primarily cardiac rehabilitation, show positive impacts. While common techniques like information provision and goal setting were identified, the specific active ingredients influencing outcomes remain unclear.

Area of Science:

  • Cardiology
  • Behavioral Science
  • Public Health

Background:

  • Cardiac rehabilitation is the primary behavioral intervention for coronary heart disease (CHD) patients.
  • Identifying the active components of behavioral interventions for CHD is crucial for optimizing effectiveness.
  • Utilizing a behavior change technique (BCT) framework can help analyze intervention content.

Purpose of the Study:

  • To systematically review the effectiveness of behavioral interventions for CHD.
  • To determine if BCT content and structure explain the effectiveness of these interventions.
  • To identify commonly used BCTs in CHD behavioral interventions.

Main Methods:

  • Systematic literature search of Medline, EMBASE, and PsycInfo databases (2003-2015).
  • Coding intervention content using the Coventry Aberdeen and London-Refined (CALO-RE) taxonomy.
  • Meta-regression analyses to examine BCTs as predictors of mortality.

Main Results:

  • Twenty-two studies (16,766 participants) were included.
  • Commonly used BCTs included providing information and goal setting.
  • Interventions significantly reduced mortality (RR = 0.82) but not CHD events.
  • No specific BCT variables or number of BCTs predicted mortality.

Conclusions:

  • Behavioral interventions for CHD patients demonstrate a positive impact on various outcomes.
  • The study identified prevalent BCTs but could not pinpoint the active components of these complex interventions.
  • Further research is needed to elucidate the specific mechanisms driving intervention effectiveness.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
837
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
571
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
431
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
395
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
408
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
605